We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$89.4M
AUM Growth
-$7.24M
(-7.5%)
Cap. Flow
+$731K
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
112
New
7
Increased
13
Reduced
63
Closed
8
Avg Time Held
15.7
quarters
Top 10 Avg Time Held
2.9
quarters
Top 20 Avg Time Held
7.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LeMaitre Vascular
LMAT
|
+$1.94M |
| 2 |
TELA Bio
TELA
|
+$1.44M |
| 3 |
VJET
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
|
+$648K |
| 4 |
Backblaze
BLZE
|
+$442K |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$270K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMED
Sharps Compliance Corp
SMED
|
+$552K |
| 2 |
AquaBounty Technologies
AQB
|
+$510K |
| 3 |
Digi International
DGII
|
+$199K |
| 4 |
RYTHM Inc
RYM
|
+$191K |
| 5 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$144K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.02% |
| 2 | Technology | 20.51% |
| 3 | Communication Services | 7.23% |
| 4 | Industrials | 7.09% |
| 5 | Consumer Staples | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$1.08T
| $4.27M | 4.78% |
13,216
-192
| -1% | -$60.8K |
2013 Q2
37 quarters
|
|
|
2
Digi International
DGII
$2.72B
| $3.82M | 4.27% |
110,433
-6,417
| -5% | -$199K |
2020 Q1
10 quarters
|
|
3
Axogen
AXGN
$2.11B
| $3.65M | 4.09% |
306,640
+700
| +0.2% | +$7K |
2013 Q3
36 quarters
|
|
4
Microsoft
MSFT
$3.98T
| $3.57M | 3.99% |
15,326
-167
| -1% | -$44.1K |
2014 Q1
34 quarters
|
|
5
Idexx Laboratories
IDXX
$41.3B
| $3.52M | 3.94% |
10,805
| – | – |
2013 Q3
36 quarters
|
|
6
Natera
NTRA
$57.5B
| $2.72M | 3.04% |
62,050
-2,650
| -4% | -$126K |
2018 Q2
17 quarters
|
|
7
Abbott
ABT
$177B
| $2.61M | 2.92% |
26,980
-100
| -0.4% | -$10.7K |
2014 Q1
34 quarters
|
|
8
DELISTED
FlexShopper
FPAY
| $2.39M | 2.67% |
1,284,940
-63,000
| -5% | -$107K |
2018 Q3
16 quarters
|
|
9
Inuvo
INUV
$7.91M
| $2.27M | 2.53% |
556,408
-24,859
| -4% | -$121K |
2018 Q2
17 quarters
|
|
10
Pfizer
PFE
$167B
| $2.24M | 2.51% |
51,216
-1,807
| -3% | -$87.8K |
2013 Q2
37 quarters
|
|
11
Perion Network
PERI
$347M
| $2.06M | 2.3% |
106,721
+3,370
| +3% | +$67.9K |
2021 Q1
6 quarters
|
|
12
Veracyte
VCYT
$3.46B
| $2.05M | 2.3% |
123,530
-4,600
| -4% | -$104K |
2018 Q1
18 quarters
|
|
|
13
LeMaitre Vascular
LMAT
$1.88B
| $1.97M | 2.21% |
+38,900
| New | +$1.94M |
2022 Q3
0 quarters
|
|
14
DELISTED
Streamline Health Solutions
STRM
| $1.93M | 2.16% |
108,109
-2,434
| -2% | -$54.7K |
2018 Q2
17 quarters
|
|
15
Ooma
OOMA
$552M
| $1.8M | 2.01% |
146,050
-3,625
| -2% | -$45K |
2018 Q2
17 quarters
|
|
16
NeoGenomics
NEO
$2.17B
| $1.68M | 1.88% |
195,550
-7,000
| -3% | -$69.5K |
2013 Q2
37 quarters
|
|
17
Advanced Micro Devices
AMD
$936B
| $1.63M | 1.82% |
25,684
-500
| -2% | -$42.6K |
2018 Q1
18 quarters
|
|
18
Alphatec Holdings
ATEC
$1.62B
| $1.61M | 1.8% |
183,717
-4,783
| -3% | -$37.8K |
2019 Q3
12 quarters
|
|
19
Elutia
ELUT
$34.4M
| $1.57M | 1.76% |
218,329
-8,400
| -4% | -$56.1K |
2020 Q4
7 quarters
|
|
20
AbbVie
ABBV
$502B
| $1.56M | 1.74% |
11,608
-417
| -3% | -$59.8K |
2019 Q1
14 quarters
|
|
21
General Mills
GIS
$17.1B
| $1.56M | 1.74% |
20,325
-850
| -4% | -$64.8K |
2017 Q4
19 quarters
|
|
22
QuickLogic
QUIK
$179M
| $1.55M | 1.74% |
240,035
-10,250
| -4% | -$76K |
2019 Q2
13 quarters
|
|
23
OptimizeRx
OPRX
$157M
| $1.5M | 1.68% |
101,563
-5,667
| -5% | -$112K |
2018 Q2
17 quarters
|
|
|
24
TELA Bio
TELA
$47.4M
| $1.48M | 1.66% |
+173,750
| New | +$1.44M |
2022 Q3
0 quarters
|
|
25
AtriCure
ATRC
$2.92B
| $1.34M | 1.5% |
34,350
| – | – |
2013 Q2
37 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Perkins Capital Management held 112 positions worth $89.4M, down 7.5% from $96.6M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management's Q3 2022 filing shows 7 new, 13 increased, 63 reduced and 8 closed positions. Its largest new stake was LeMaitre Vascular: 38,900 shares worth $1.97M. The largest sale was Sharps Compliance Corp, an estimated $552K.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 55% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q3 2022 buy was LeMaitre Vascular: 38,900 shares worth $1.97M.
- Perkins Capital Management added most to UpHealth, Inc. in Q3 2022, an estimated $171K increase.
- Perkins Capital Management's biggest Q3 2022 reduction was Digi International, cutting an estimated $199K.
- Perkins Capital Management fully exited Sharps Compliance Corp in Q3 2022, selling an estimated $552K.
- Perkins Capital Management's ten largest holdings make up 35% of its $89.4M portfolio in Q3 2022.
- Perkins Capital Management opened 7 new positions and closed 8 in Q3 2022.
- Perkins Capital Management's portfolio value fell 7.5% quarter-over-quarter to $89.4M.
Based on Perkins Capital Management's 13F filing for Q3 2022, filed 24 Oct 2022.